Dec.06 -- A Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE could be in use by Friday if the Food and Drug Administration approves an emergency use authorization, James Hildreth, a member of the FDA’s vaccine advisory committee, told NBC News. Tony Czuczka reports on "Bloomberg Daybreak: Asia."